[Alpha Tau in Globe Newswire] Alpha Tau successfully treats first recurrent glioblastoma patient outside of the United States with Alpha DaRT® at Hadassah University Medical Center in Israel

JERUSALEM, June 23, 2026 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced the successful treatment with Alpha DaRT of the first glioblastoma patient in Israel, and the first ever outside of the United States, performed at Hadassah University Medical Center in Jerusalem. 

Read more here.